In the case of tirzepatide, it is known to cause thyroid C-cell tumors in rats, and it remains unknown if there is cancer risk in humans
Gut-brain axis: GLP-1 is a peptide hormone (a small protein molecule) that is released in the upper part of the intestinal tract when you eat carbohydrates or certain proteins
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have garnered recognition as potentially revolutionary therapeutic modalities for MASLD/MASH management, offering multifaceted benefits extending beyond glycemic regulation
Together, these incretins contribute significantly to insulin secretion following oral glucose intake, a phenomenon known as the incretin effect
Key hypothalamic centers, including the arcuate and paraventricular nuclei, exhibit high GLP-1 receptors expression, which coordinate peripheral metabolic cues to modulate feeding behavior and energy balance [34]